Title Anticoagulation Therapy, 2/e
Subtitle A Clinical Practice Guide
Author William E. Dager, Michael P. Gulseth , Edith A. Nutescu
ISBN 9781585284894
List price USD 79.00
Price outside India Available on Request
Original price
Binding Paperback
No of pages 550
Book size 153 x 229 mm
Publishing year 2018
Original publisher ASHP - American Society of Health-System Pharmacists (Eurospan Group)
Published in India by .
Exclusive distributors Viva Books Private Limited
Sales territory India, Sri Lanka, Bangladesh, Pakistan, Nepal, .
Status New Arrival
About the book Send Enquiry


Although highly effective in preventing thromboembolic events, the safe management of anticoagulant therapy continues to be a major challenge, requiring constant monitoring and coordinated models of patient-centered care.

Anticoagulation Therapy: A Clinical Practice Guide, Second Edition, helps take the guesswork out of managing these therapies and provides essential recommendations.

This revised and expanded edition includes:

  • Extensive new information on the direct oral anticoagulants (DOACs)
  • Expanded information on anticoagulant reversal and expanded use of prothrombin complex concentrates
  • New chapters on the use of anticoagulants in special patient populations, the use of anticoagulants in patients with mechanical devices, anticoagulation care delivery standards, regulatory issues, and more
  • Four new appendices on the effect of DOACs on chemotherapy, nutritional influences, types of central nervous system hemorrhage, and use of anticoagulation in patients with coagulopathies







Part I: Anticoagulation Medication Management


Chapter 1: Introduction to Anticoagulation Management (William E. Dager, Michael P. Gulseth, and Edith A. Nutescu)

Chapter 2: Warfarin  (Ann K. Wittkowsky)

Chapter 3: Unfractionated Heparin (William E. Dager)

Chapter 4: Low Molecular Weight Heparin and Fondaparinux (Zachary Stacy and Sara K. Richter)

Chapter 5: Parenteral Direct Thrombin Inhibitors (William E. Dager and A. Joshua Roberts)

Chapter 6: Thrombolytic Considerations When Used with Anticoagulants (Toby C. Trujillo and Tyree H. Kiser)

Chapter 7: Direct Oral Anticoagulants (Allison E. Burnett and Candice L. Garwood)

Chapter 8: Anticoagulation Reversal: Part I—Pharmacology of Agents Useds for Reversal  (Lance J. Oyen and Scott A. Chapman)

Chapter 9: Anticoagulation Reversal: Part II—Clinical Application (William E. Dager)

Chapter 10: Transitions in Care—Periprocedural Bridging and Transitions Between Agents (Jessica Rimsans, Katelyn W. Sylvester, and John Fanikos)

Chapter 11: Considerations on Special Populations (Thaddaus Hellwig and William E. Dager)


Part II: Conditions Requiring Anticoagulation Therapy


Chapter 12: Venous Thromboembolism Prevention (Paul P. Dobesh and Kelsey Aker)

Chapter 13: Venous Thromboembolism Treatment (Snehal H. Bhatt and Michael P. Gulseth)

Chapter 14: Atrial Fibrillation (Daniel M, Witt)

Chapter 15: Acute Coronary Syndromes (Sarah A. Spinler)

Chapter 16: Prosthetic Heart Valves (Douglas C. Anderson)

Chapter 17: Mechanical Circulatory Support Devices (Christopher Paciullo, Laura Baumgartner, and Lauren Roller)

Chapter 18: Heparin-Induced Thrombocytopenia (William E. Dager)

Chapter 19: Pregnancy (Nancy L. Shapiro)

Chapter 20: Pediatrics (Kirsten H. Ohler)


Part III: Practical Measuring, Monitoring, and Coagulation Laboratory Insights


Chapter 21: Coagulation Laboratory Considerations (Robert C. Gosselin and Maureen A. Symthe)

Chapter 22: Thrombophilias (Jessica B. Michaud and Canice A. Coan)


Part IV: Essentials for Practice Success


Chapter 23: Models and Standards of Anticoagulation Care Delivery (Nathan P. Clark and Paul B. Shaw)

Chapter 24: Regulatory and Practice Resources (Michael P. Gulseth and William E. Dager)


Appendix A. Coagulation Cascade

Appendix B. Agents Implicated in Drug-Induced Thromboembolic Diseases

Appendix C. Nutrition Influence on Anticoagulation

Appendix D. Anticoagulants in Management of Ischemic Stroke or Transient Ischemic Attacks

Appendix E. Citrate Anticoagulation

Appendix F. Examples of Avaliable Bleeding Definitions

Appendix G. Types of CNS Hemorrhage

Appendix H. Disseminated Intravascular Coagulation

Appendix I. Nondrug Causes of Thrombocytopenia

Appendix J. Drug-Related Causes of Thrombocytopenia

Appendix K. Examples of Transfusion-Related Reactions

Appendix L. Considerations for Transitioning from aPTT to Anti-Xa to Manage Heparin Therapy


Appendix N. Betrixaban APEX Trial


About the Editors:

The second edition of this critical reference text is edited by William E. Dager, PharmD, BCPS (AQ Cardiology), FCSHP, FCCP, FCCM, FASHP, MCCM

Michael P. Gulseth, PharmD, BCPS, and Edith A. Nutescu, PharmD, MS CTS, FCCP, and written by the elite anticoagulation pharmacist clinicians.

Target Audience:

It is a useful guide for clinicians in any discipline caring for patients on anticoagulation therapy.


Special prices are applicable to the authorised sales territory only.
Prices are subject to change without prior notice.